© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#SABCS 2017
Click Here for More Conferences
Click Here for SABCS Online
Cancer Basics
3D rendering of the breast

FDA Approves Kisqali for Premenopausal Women With Advanced Breast Cancer

First approval using a new FDA process to speed up cancer drug reviews.

Kisqali Improves Outcomes for Premenopausal Women With Advanced Breast Cancer

CDK4/6 inhibitor plus hormone therapy extends progression-free survival for younger women.
The U.N. General Assembly Hall during the High-level Meeting on HIV/AIDS.

Conferences

3D rendering of the breast

New PARP Inhibitor Improves Survival in Women With Advanced Breast Cancer

Talazoparib may offer an additional option for women with BRCA gene mutations.
Rowan Chlebowski, MD, at SABCS17

Women Who Lose Weight Can Lower Their Breast Cancer Risk

SABCS17 study shows that losing 5 percent of body weight reduced cancer risk by 12 percent.
April Hines and April Knowles of METUP

Activists and Advocates at #SABCS17

Direct action and legislative advocacy groups demand more awareness and research on metastatic breast cancer.

Hot topics

#Immunotherapy
#Chemotherapy

Acupuncture Relieves Joint Pain Caused by Hormone Therapy

Reducing the side effects of aromatase inhibitors may help women stay on treatment.
Sherene Loi speaks at SABCS17

Immunotherapy Improves Outcomes for Women With Advanced Breast Cancer

Keytruda may restore immune function in some women who develop resistance to Herceptin.

Exciting Breast Cancer Research Presented at #SABCS17

World’s largest breast cancer conference celebrates 40 years.
Advertisement
Treatment News
Newsfeed
Features
Opinions